{"title":"神经变性的遗传修饰因子。","authors":"Nimansha Jain, Alice S Chen-Plotkin","doi":"10.1007/s40142-018-0133-1","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose of review: </strong>To review the evidence for genetic modifier effects in the neurodegenerative diseases Huntington's Disease (HD), Frontotemporal Lobar Degeneration (FTLD), Alzheimer's Disease (AD), and Parkinson's Disease (PD).</p><p><strong>Recent findings: </strong>Increasingly, we understand human disease genetics less through the lens of single-locus/single-trait effects, and more through that of polygenic contributions to disease risk. In addition, specific examples of genetic modifier effects of the chromosome 7 gene <i>TMEM106B</i> on various target genes including those causal for Mendelian classes of FTLD - <i>GRN</i> and <i>c9orf72</i> - have emerged from both genetic cohort studies and mechanistic examinations of biological pathways.</p><p><strong>Summary: </strong>Here, we summarize the literature reporting genetic modifier effects in HD, FTLD, AD, and PD. We further contextualize reported genetic modifier effects in these diseases in terms of insight they may lend to the concept of a polygenic landscape for the major neurodegenerative diseases.</p>","PeriodicalId":72731,"journal":{"name":"Current genetic medicine reports","volume":"6 1","pages":"11-19"},"PeriodicalIF":1.4000,"publicationDate":"2018-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s40142-018-0133-1","citationCount":"12","resultStr":"{\"title\":\"Genetic Modifiers in Neurodegeneration.\",\"authors\":\"Nimansha Jain, Alice S Chen-Plotkin\",\"doi\":\"10.1007/s40142-018-0133-1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose of review: </strong>To review the evidence for genetic modifier effects in the neurodegenerative diseases Huntington's Disease (HD), Frontotemporal Lobar Degeneration (FTLD), Alzheimer's Disease (AD), and Parkinson's Disease (PD).</p><p><strong>Recent findings: </strong>Increasingly, we understand human disease genetics less through the lens of single-locus/single-trait effects, and more through that of polygenic contributions to disease risk. In addition, specific examples of genetic modifier effects of the chromosome 7 gene <i>TMEM106B</i> on various target genes including those causal for Mendelian classes of FTLD - <i>GRN</i> and <i>c9orf72</i> - have emerged from both genetic cohort studies and mechanistic examinations of biological pathways.</p><p><strong>Summary: </strong>Here, we summarize the literature reporting genetic modifier effects in HD, FTLD, AD, and PD. We further contextualize reported genetic modifier effects in these diseases in terms of insight they may lend to the concept of a polygenic landscape for the major neurodegenerative diseases.</p>\",\"PeriodicalId\":72731,\"journal\":{\"name\":\"Current genetic medicine reports\",\"volume\":\"6 1\",\"pages\":\"11-19\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2018-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1007/s40142-018-0133-1\",\"citationCount\":\"12\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current genetic medicine reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s40142-018-0133-1\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2018/2/5 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"GENETICS & HEREDITY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current genetic medicine reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s40142-018-0133-1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2018/2/5 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
Purpose of review: To review the evidence for genetic modifier effects in the neurodegenerative diseases Huntington's Disease (HD), Frontotemporal Lobar Degeneration (FTLD), Alzheimer's Disease (AD), and Parkinson's Disease (PD).
Recent findings: Increasingly, we understand human disease genetics less through the lens of single-locus/single-trait effects, and more through that of polygenic contributions to disease risk. In addition, specific examples of genetic modifier effects of the chromosome 7 gene TMEM106B on various target genes including those causal for Mendelian classes of FTLD - GRN and c9orf72 - have emerged from both genetic cohort studies and mechanistic examinations of biological pathways.
Summary: Here, we summarize the literature reporting genetic modifier effects in HD, FTLD, AD, and PD. We further contextualize reported genetic modifier effects in these diseases in terms of insight they may lend to the concept of a polygenic landscape for the major neurodegenerative diseases.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
